Co-Authors
This is a "connection" page, showing publications co-authored by Roger Brüggemann and Jeroen Schouten.
Connection Strength
0.465
-
Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals. Int J Antimicrob Agents. 2021 Mar; 57(3):106293.
Score: 0.232
-
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021 08; 47(8):819-834.
Score: 0.060
-
COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion. Lancet Respir Med. 2021 07; 9(7):795-802.
Score: 0.059
-
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. J Infect Dis. 2021 04 23; 223(8):1322-1333.
Score: 0.059
-
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Aug; 46(8):1524-1535.
Score: 0.056